U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Falciform retinal fold

MedGen UID:
488857
Concept ID:
C0344550
Congenital Abnormality
Synonym: Falciform retinal folds
SNOMED CT: Congenital retinal fold (204181009)
 
HPO: HP:0001493

Definition

An area of the retina that is buckled so that a sector-shaped sheet of retina lies in front of the normal retina. This feature is of congenital onset. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVFalciform retinal fold

Conditions with this feature

Exudative vitreoretinopathy 2, X-linked
MedGen UID:
337030
Concept ID:
C1844579
Disease or Syndrome
Familial exudative vitreoretinopathy (FEVR) is an inherited disorder characterized by the incomplete development of the retinal vasculature. Its clinical appearance varies considerably, even within families, with severely affected patients often registered as blind during infancy, whereas mildly affected patients with few or no visual problems may have such a small area of avascularity in their peripheral retina that it is visible only by fluorescein angiography. It is believed that this peripheral avascularity is the primary anomaly in FEVR and results from defective retinal angiogenesis. The sight-threatening features of the FEVR phenotype are considered secondary to retinal avascularity and develop because of the resulting retinal ischemia; they include the development of hyperpermeable blood vessels, neovascularization, vitreoretinal traction, retinal folds, and retinal detachments (summary by Poulter et al., 2010). For a discussion of genetic heterogeneity of FEVR, see EVR1 (133780).
Exudative vitreoretinopathy 1
MedGen UID:
343561
Concept ID:
C1851402
Disease or Syndrome
Familial exudative vitreoretinopathy (FEVR) is an inherited disorder characterized by the incomplete development of the retinal vasculature. Its clinical appearance varies considerably, even within families, with severely affected patients often registered as blind during infancy, whereas mildly affected patients with few or no visual problems may have such a small area of avascularity in their peripheral retina that it is visible only by fluorescein angiography. It is believed that this peripheral avascularity is the primary anomaly in FEVR and results from defective retinal angiogenesis. The sight-threatening features of the FEVR phenotype are considered secondary to retinal avascularity and develop because of the resulting retinal ischemia; they include the development of hyperpermeable blood vessels, neovascularization, vitreoretinal traction, retinal folds, and retinal detachments (summary by Poulter et al., 2010). In 31 Chinese pedigrees clinically diagnosed with FEVR, Rao et al. (2017) analyzed 6 FEVR-associated genes and identified mutations in 12 of the probands, including 5 (16.1%) in LRP5, 3 (9.7%) in NDP, 2 (6.5%) in FZD4, and 1 (3.2%) in TSPAN12. In addition, a mutation in the KIF11 gene (148760) was identified in a patient who also exhibited microcephaly (MCLMR; 152950). The authors noted that their detection rate did not exceed 50%, suggesting that other FEVR-associated genes remained to be discovered. Genetic Heterogeneity of Familial Exudative Vitreoretinopathy Also see EVR2 (305390), caused by mutation in the NDP gene (300658) on chromosome Xp11; EVR3 (605750), mapped to 11p13-p12; EVR4 (601813), caused by mutations in the LRP5 gene (603506) on 11q13.4; EVR5 (613310), caused by mutation in the TSPAN12 gene (613138) on 7q31; EVR6 (616468), caused by mutation in the ZNF408 gene (616454) on 11p11; and EVR7 (617572), caused by mutation in the CTNNB1 gene (116806) on chromosome 3p22.
Exudative vitreoretinopathy 4
MedGen UID:
356171
Concept ID:
C1866176
Disease or Syndrome
Familial exudative vitreoretinopathy (FEVR) is an inherited disorder characterized by the incomplete development of the retinal vasculature. Its clinical appearance varies considerably, even within families, with severely affected patients often registered as blind during infancy, whereas mildly affected patients with few or no visual problems may have such a small area of avascularity in their peripheral retina that it is visible only by fluorescein angiography. It is believed that this peripheral avascularity is the primary anomaly in FEVR and results from defective retinal angiogenesis. The sight-threatening features of the FEVR phenotype are considered secondary to retinal avascularity and develop because of the resulting retinal ischemia; they include the development of hyperpermeable blood vessels, neovascularization, vitreoretinal traction, retinal folds, and retinal detachments (summary by Poulter et al., 2010). For a discussion of genetic heterogeneity of familial exudative vitreoretinopathy, see EVR1 (133780).
Exudative vitreoretinopathy 5
MedGen UID:
412872
Concept ID:
C2750079
Disease or Syndrome
Familial exudative vitreoretinopathy is an inherited blinding disorder caused by defects in the development of retinal vasculature. There is extensive variation in disease severity among patients, even between members of the same family. Severely affected individuals often are registered as blind during infancy and can present with a phenotype resembling retinal dysplasia. Conversely, mildly affected individuals frequently have few or no visual problems and may have just a small area of avascularity in their peripheral retina, detectable only by fluorescein angiography (summary by Poulter et al., 2012). For a discussion of genetic heterogeneity of familial exudative vitreoretinopathy (FEVR), see EVR1 (133780).
Retinal dysplasia, primary
MedGen UID:
854679
Concept ID:
C3887971
Disease or Syndrome
Exudative vitreoretinopathy 6
MedGen UID:
902559
Concept ID:
C4225316
Disease or Syndrome
Familial exudative vitreoretinopathy is a hereditary disorder that can cause vision loss that worsens over time. This condition affects the retina, the specialized light-sensitive tissue that lines the back of the eye. In people with this disorder, blood vessels do not fully develop at the outer edges (periphery) of the retina, which reduces the blood supply to this tissue. This prolonged reduction in blood supply (chronic ischemia) causes continued damage to the retina and can lead to worsening of the condition. \n\nSome people with familial exudative vitreoretinopathy also have a condition known as osteoporosis-pseudoglioma syndrome, which is characterized by reduced bone density. People with this condition have weakened bones and an increased risk of fractures.\n\nThe signs and symptoms of familial exudative vitreoretinopathy vary widely, even within the same family. In many affected individuals, the retinal abnormalities never cause any vision problems. Other people with this condition develop abnormal vessels that leak. This  causes chronic inflammation which, over time, can lead to fluid under the retina (exudate). A reduction in the retina's blood supply causes the retina to fold, tear, or separate from the back of the eye (retinal detachment). The resulting retinal damage can lead to vision loss and blindness. Other eye abnormalities are also possible, including eyes that do not look in the same direction (strabismus) and a visible whiteness (leukocoria) in the normally black pupil.

Professional guidelines

PubMed

Chen C, Sun L, Li S, Huang L, Zhang T, Wang Z, Yu B, Luo X, Ding X
Exp Eye Res 2020 Oct;199:108165. Epub 2020 Jul 28 doi: 10.1016/j.exer.2020.108165. PMID: 32730767

Recent clinical studies

Etiology

Chen C, Sun L, Li S, Huang L, Zhang T, Wang Z, Yu B, Luo X, Ding X
Exp Eye Res 2020 Oct;199:108165. Epub 2020 Jul 28 doi: 10.1016/j.exer.2020.108165. PMID: 32730767
Kim HY, Yu YS
Korean J Ophthalmol 1998 Dec;12(2):98-102. doi: 10.3341/kjo.1998.12.2.98. PMID: 10188369
Fujii M, Hayasaka S, Setogawa T
Ophthalmologica 1989;198(3):135-9. doi: 10.1159/000309977. PMID: 2498796
Nishimura M, Yamana T, Sugino M, Kohno T, Yamana Y, Minei M, Sanui H
Jpn J Ophthalmol 1983;27(1):40-53. PMID: 6855020

Diagnosis

Chen C, Sun L, Li S, Huang L, Zhang T, Wang Z, Yu B, Luo X, Ding X
Exp Eye Res 2020 Oct;199:108165. Epub 2020 Jul 28 doi: 10.1016/j.exer.2020.108165. PMID: 32730767
Ben Amor S, Trigui A, Ennouri A, Feki J
J Fr Ophtalmol 2017 Jan;40(1):87-88. Epub 2016 Dec 2 doi: 10.1016/j.jfo.2016.08.010. PMID: 27916430
Khetan V, Zanolli M, Capasso J, Refice NZ, Neeley K, Levin AV
Indian J Ophthalmol 2016 May;64(5):399-402. doi: 10.4103/0301-4738.185629. PMID: 27380984Free PMC Article
Kim HY, Yu YS
Korean J Ophthalmol 1998 Dec;12(2):98-102. doi: 10.3341/kjo.1998.12.2.98. PMID: 10188369
Nicholson DH, Galvis V
Arch Ophthalmol 1984 Oct;102(10):1519-22. doi: 10.1001/archopht.1984.01040031239027. PMID: 6487118

Prognosis

van Nouhuys CE
Am J Ophthalmol 1991 Jan 15;111(1):34-41. doi: 10.1016/s0002-9394(14)76893-x. PMID: 1985487

Clinical prediction guides

Chen C, Sun L, Li S, Huang L, Zhang T, Wang Z, Yu B, Luo X, Ding X
Exp Eye Res 2020 Oct;199:108165. Epub 2020 Jul 28 doi: 10.1016/j.exer.2020.108165. PMID: 32730767
van Nouhuys CE
Am J Ophthalmol 1991 Jan 15;111(1):34-41. doi: 10.1016/s0002-9394(14)76893-x. PMID: 1985487
Miyakubo H, Hashimoto K, Miyakubo S
Ophthalmology 1984 Dec;91(12):1524-30. doi: 10.1016/s0161-6420(84)34119-7. PMID: 6084219
Nishimura M, Yamana T, Sugino M, Kohno T, Yamana Y, Minei M, Sanui H
Jpn J Ophthalmol 1983;27(1):40-53. PMID: 6855020

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...